Global Biologics and Biosimilars Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 198790 million in 2022 and is forecast to a readjusted size of USD 277500 million by 2029 with a CAGR of 4.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major global manufacturers of biologics and biosimilars are Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Sansheng Pharmaceuticals, Changchun Gaoxin, CITICS Guojia, Baitai Biotech, Sijin Biotech, Cinda Biotech, Tonghua Dongbao, Ganli and Union Pharmaceuticals, etc. Roche, Amgen and AbbVie are the top three, with a combined market share of about 37%.
This report is a detailed and comprehensive analysis for global Biologics and Biosimilars market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biologics and Biosimilars market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Biologics and Biosimilars market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Biologics and Biosimilars market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Biologics and Biosimilars market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologics and Biosimilars
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologics and Biosimilars market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi-Aventis and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Biologics and Biosimilars market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Biologics and Biosimilars product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologics and Biosimilars, with price, sales, revenue and global market share of Biologics and Biosimilars from 2018 to 2023.
Chapter 3, the Biologics and Biosimilars competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics and Biosimilars breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologics and Biosimilars.
Chapter 14 and 15, to describe Biologics and Biosimilars sales channel, distributors, customers, research findings and conclusion.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 198790 million in 2022 and is forecast to a readjusted size of USD 277500 million by 2029 with a CAGR of 4.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major global manufacturers of biologics and biosimilars are Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Sansheng Pharmaceuticals, Changchun Gaoxin, CITICS Guojia, Baitai Biotech, Sijin Biotech, Cinda Biotech, Tonghua Dongbao, Ganli and Union Pharmaceuticals, etc. Roche, Amgen and AbbVie are the top three, with a combined market share of about 37%.
This report is a detailed and comprehensive analysis for global Biologics and Biosimilars market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biologics and Biosimilars market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Biologics and Biosimilars market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Biologics and Biosimilars market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Biologics and Biosimilars market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologics and Biosimilars
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologics and Biosimilars market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi-Aventis and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Biologics and Biosimilars market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Monoclonal Antibodies
- Interferon
- Erythropoietin
- Insulin
- Vaccines
- Others
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Others
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- 3sbio
- Changchun High Tech
- CP Guojian
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
- United Laboratories
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Biologics and Biosimilars product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologics and Biosimilars, with price, sales, revenue and global market share of Biologics and Biosimilars from 2018 to 2023.
Chapter 3, the Biologics and Biosimilars competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics and Biosimilars breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologics and Biosimilars.
Chapter 14 and 15, to describe Biologics and Biosimilars sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biologics and Biosimilars Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monoclonal Antibodies
1.3.3 Interferon
1.3.4 Erythropoietin
1.3.5 Insulin
1.3.6 Vaccines
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Biologics and Biosimilars Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tumor
1.4.3 Diabetes
1.4.4 Cardiovascular
1.4.5 Hemophilia
1.4.6 Others
1.5 Global Biologics and Biosimilars Market Size & Forecast
1.5.1 Global Biologics and Biosimilars Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Biologics and Biosimilars Sales Quantity (2018-2029)
1.5.3 Global Biologics and Biosimilars Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biologics and Biosimilars Product and Services
2.1.4 Roche Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biologics and Biosimilars Product and Services
2.2.4 Amgen Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments/Updates
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biologics and Biosimilars Product and Services
2.3.4 AbbVie Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AbbVie Recent Developments/Updates
2.4 Sanofi-Aventis
2.4.1 Sanofi-Aventis Details
2.4.2 Sanofi-Aventis Major Business
2.4.3 Sanofi-Aventis Biologics and Biosimilars Product and Services
2.4.4 Sanofi-Aventis Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sanofi-Aventis Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Biologics and Biosimilars Product and Services
2.5.4 Johnson & Johnson Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Biologics and Biosimilars Product and Services
2.6.4 Pfizer Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Recent Developments/Updates
2.7 Novo Nordisk
2.7.1 Novo Nordisk Details
2.7.2 Novo Nordisk Major Business
2.7.3 Novo Nordisk Biologics and Biosimilars Product and Services
2.7.4 Novo Nordisk Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novo Nordisk Recent Developments/Updates
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business
2.8.3 Eli Lilly Biologics and Biosimilars Product and Services
2.8.4 Eli Lilly Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eli Lilly Recent Developments/Updates
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Biologics and Biosimilars Product and Services
2.9.4 Novartis Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Novartis Recent Developments/Updates
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck Biologics and Biosimilars Product and Services
2.10.4 Merck Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck Recent Developments/Updates
2.11 3sbio
2.11.1 3sbio Details
2.11.2 3sbio Major Business
2.11.3 3sbio Biologics and Biosimilars Product and Services
2.11.4 3sbio Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 3sbio Recent Developments/Updates
2.12 Changchun High Tech
2.12.1 Changchun High Tech Details
2.12.2 Changchun High Tech Major Business
2.12.3 Changchun High Tech Biologics and Biosimilars Product and Services
2.12.4 Changchun High Tech Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Changchun High Tech Recent Developments/Updates
2.13 CP Guojian
2.13.1 CP Guojian Details
2.13.2 CP Guojian Major Business
2.13.3 CP Guojian Biologics and Biosimilars Product and Services
2.13.4 CP Guojian Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 CP Guojian Recent Developments/Updates
2.14 Biotech
2.14.1 Biotech Details
2.14.2 Biotech Major Business
2.14.3 Biotech Biologics and Biosimilars Product and Services
2.14.4 Biotech Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Biotech Recent Developments/Updates
2.15 Gelgen
2.15.1 Gelgen Details
2.15.2 Gelgen Major Business
2.15.3 Gelgen Biologics and Biosimilars Product and Services
2.15.4 Gelgen Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Gelgen Recent Developments/Updates
2.16 Innovent
2.16.1 Innovent Details
2.16.2 Innovent Major Business
2.16.3 Innovent Biologics and Biosimilars Product and Services
2.16.4 Innovent Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Innovent Recent Developments/Updates
2.17 Dong Bao
2.17.1 Dong Bao Details
2.17.2 Dong Bao Major Business
2.17.3 Dong Bao Biologics and Biosimilars Product and Services
2.17.4 Dong Bao Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Dong Bao Recent Developments/Updates
2.18 Ganlee
2.18.1 Ganlee Details
2.18.2 Ganlee Major Business
2.18.3 Ganlee Biologics and Biosimilars Product and Services
2.18.4 Ganlee Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Ganlee Recent Developments/Updates
2.19 United Laboratories
2.19.1 United Laboratories Details
2.19.2 United Laboratories Major Business
2.19.3 United Laboratories Biologics and Biosimilars Product and Services
2.19.4 United Laboratories Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 United Laboratories Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGICS AND BIOSIMILARS BY MANUFACTURER
3.1 Global Biologics and Biosimilars Sales Quantity by Manufacturer (2018-2023)
3.2 Global Biologics and Biosimilars Revenue by Manufacturer (2018-2023)
3.3 Global Biologics and Biosimilars Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Biologics and Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2022
3.4.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2022
3.5 Biologics and Biosimilars Market: Overall Company Footprint Analysis
3.5.1 Biologics and Biosimilars Market: Region Footprint
3.5.2 Biologics and Biosimilars Market: Company Product Type Footprint
3.5.3 Biologics and Biosimilars Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biologics and Biosimilars Market Size by Region
4.1.1 Global Biologics and Biosimilars Sales Quantity by Region (2018-2029)
4.1.2 Global Biologics and Biosimilars Consumption Value by Region (2018-2029)
4.1.3 Global Biologics and Biosimilars Average Price by Region (2018-2029)
4.2 North America Biologics and Biosimilars Consumption Value (2018-2029)
4.3 Europe Biologics and Biosimilars Consumption Value (2018-2029)
4.4 Asia-Pacific Biologics and Biosimilars Consumption Value (2018-2029)
4.5 South America Biologics and Biosimilars Consumption Value (2018-2029)
4.6 Middle East and Africa Biologics and Biosimilars Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Biologics and Biosimilars Sales Quantity by Type (2018-2029)
5.2 Global Biologics and Biosimilars Consumption Value by Type (2018-2029)
5.3 Global Biologics and Biosimilars Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biologics and Biosimilars Sales Quantity by Application (2018-2029)
6.2 Global Biologics and Biosimilars Consumption Value by Application (2018-2029)
6.3 Global Biologics and Biosimilars Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Biologics and Biosimilars Sales Quantity by Type (2018-2029)
7.2 North America Biologics and Biosimilars Sales Quantity by Application (2018-2029)
7.3 North America Biologics and Biosimilars Market Size by Country
7.3.1 North America Biologics and Biosimilars Sales Quantity by Country (2018-2029)
7.3.2 North America Biologics and Biosimilars Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Biologics and Biosimilars Sales Quantity by Type (2018-2029)
8.2 Europe Biologics and Biosimilars Sales Quantity by Application (2018-2029)
8.3 Europe Biologics and Biosimilars Market Size by Country
8.3.1 Europe Biologics and Biosimilars Sales Quantity by Country (2018-2029)
8.3.2 Europe Biologics and Biosimilars Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biologics and Biosimilars Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Biologics and Biosimilars Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Biologics and Biosimilars Market Size by Region
9.3.1 Asia-Pacific Biologics and Biosimilars Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Biologics and Biosimilars Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Biologics and Biosimilars Sales Quantity by Type (2018-2029)
10.2 South America Biologics and Biosimilars Sales Quantity by Application (2018-2029)
10.3 South America Biologics and Biosimilars Market Size by Country
10.3.1 South America Biologics and Biosimilars Sales Quantity by Country (2018-2029)
10.3.2 South America Biologics and Biosimilars Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biologics and Biosimilars Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Biologics and Biosimilars Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Biologics and Biosimilars Market Size by Country
11.3.1 Middle East & Africa Biologics and Biosimilars Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Biologics and Biosimilars Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Biologics and Biosimilars Market Drivers
12.2 Biologics and Biosimilars Market Restraints
12.3 Biologics and Biosimilars Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biologics and Biosimilars and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologics and Biosimilars
13.3 Biologics and Biosimilars Production Process
13.4 Biologics and Biosimilars Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologics and Biosimilars Typical Distributors
14.3 Biologics and Biosimilars Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biologics and Biosimilars Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monoclonal Antibodies
1.3.3 Interferon
1.3.4 Erythropoietin
1.3.5 Insulin
1.3.6 Vaccines
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Biologics and Biosimilars Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tumor
1.4.3 Diabetes
1.4.4 Cardiovascular
1.4.5 Hemophilia
1.4.6 Others
1.5 Global Biologics and Biosimilars Market Size & Forecast
1.5.1 Global Biologics and Biosimilars Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Biologics and Biosimilars Sales Quantity (2018-2029)
1.5.3 Global Biologics and Biosimilars Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biologics and Biosimilars Product and Services
2.1.4 Roche Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biologics and Biosimilars Product and Services
2.2.4 Amgen Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments/Updates
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biologics and Biosimilars Product and Services
2.3.4 AbbVie Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AbbVie Recent Developments/Updates
2.4 Sanofi-Aventis
2.4.1 Sanofi-Aventis Details
2.4.2 Sanofi-Aventis Major Business
2.4.3 Sanofi-Aventis Biologics and Biosimilars Product and Services
2.4.4 Sanofi-Aventis Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sanofi-Aventis Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Biologics and Biosimilars Product and Services
2.5.4 Johnson & Johnson Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Biologics and Biosimilars Product and Services
2.6.4 Pfizer Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Recent Developments/Updates
2.7 Novo Nordisk
2.7.1 Novo Nordisk Details
2.7.2 Novo Nordisk Major Business
2.7.3 Novo Nordisk Biologics and Biosimilars Product and Services
2.7.4 Novo Nordisk Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novo Nordisk Recent Developments/Updates
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business
2.8.3 Eli Lilly Biologics and Biosimilars Product and Services
2.8.4 Eli Lilly Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eli Lilly Recent Developments/Updates
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Biologics and Biosimilars Product and Services
2.9.4 Novartis Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Novartis Recent Developments/Updates
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck Biologics and Biosimilars Product and Services
2.10.4 Merck Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck Recent Developments/Updates
2.11 3sbio
2.11.1 3sbio Details
2.11.2 3sbio Major Business
2.11.3 3sbio Biologics and Biosimilars Product and Services
2.11.4 3sbio Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 3sbio Recent Developments/Updates
2.12 Changchun High Tech
2.12.1 Changchun High Tech Details
2.12.2 Changchun High Tech Major Business
2.12.3 Changchun High Tech Biologics and Biosimilars Product and Services
2.12.4 Changchun High Tech Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Changchun High Tech Recent Developments/Updates
2.13 CP Guojian
2.13.1 CP Guojian Details
2.13.2 CP Guojian Major Business
2.13.3 CP Guojian Biologics and Biosimilars Product and Services
2.13.4 CP Guojian Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 CP Guojian Recent Developments/Updates
2.14 Biotech
2.14.1 Biotech Details
2.14.2 Biotech Major Business
2.14.3 Biotech Biologics and Biosimilars Product and Services
2.14.4 Biotech Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Biotech Recent Developments/Updates
2.15 Gelgen
2.15.1 Gelgen Details
2.15.2 Gelgen Major Business
2.15.3 Gelgen Biologics and Biosimilars Product and Services
2.15.4 Gelgen Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Gelgen Recent Developments/Updates
2.16 Innovent
2.16.1 Innovent Details
2.16.2 Innovent Major Business
2.16.3 Innovent Biologics and Biosimilars Product and Services
2.16.4 Innovent Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Innovent Recent Developments/Updates
2.17 Dong Bao
2.17.1 Dong Bao Details
2.17.2 Dong Bao Major Business
2.17.3 Dong Bao Biologics and Biosimilars Product and Services
2.17.4 Dong Bao Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Dong Bao Recent Developments/Updates
2.18 Ganlee
2.18.1 Ganlee Details
2.18.2 Ganlee Major Business
2.18.3 Ganlee Biologics and Biosimilars Product and Services
2.18.4 Ganlee Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Ganlee Recent Developments/Updates
2.19 United Laboratories
2.19.1 United Laboratories Details
2.19.2 United Laboratories Major Business
2.19.3 United Laboratories Biologics and Biosimilars Product and Services
2.19.4 United Laboratories Biologics and Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 United Laboratories Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGICS AND BIOSIMILARS BY MANUFACTURER
3.1 Global Biologics and Biosimilars Sales Quantity by Manufacturer (2018-2023)
3.2 Global Biologics and Biosimilars Revenue by Manufacturer (2018-2023)
3.3 Global Biologics and Biosimilars Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Biologics and Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2022
3.4.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2022
3.5 Biologics and Biosimilars Market: Overall Company Footprint Analysis
3.5.1 Biologics and Biosimilars Market: Region Footprint
3.5.2 Biologics and Biosimilars Market: Company Product Type Footprint
3.5.3 Biologics and Biosimilars Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biologics and Biosimilars Market Size by Region
4.1.1 Global Biologics and Biosimilars Sales Quantity by Region (2018-2029)
4.1.2 Global Biologics and Biosimilars Consumption Value by Region (2018-2029)
4.1.3 Global Biologics and Biosimilars Average Price by Region (2018-2029)
4.2 North America Biologics and Biosimilars Consumption Value (2018-2029)
4.3 Europe Biologics and Biosimilars Consumption Value (2018-2029)
4.4 Asia-Pacific Biologics and Biosimilars Consumption Value (2018-2029)
4.5 South America Biologics and Biosimilars Consumption Value (2018-2029)
4.6 Middle East and Africa Biologics and Biosimilars Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Biologics and Biosimilars Sales Quantity by Type (2018-2029)
5.2 Global Biologics and Biosimilars Consumption Value by Type (2018-2029)
5.3 Global Biologics and Biosimilars Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biologics and Biosimilars Sales Quantity by Application (2018-2029)
6.2 Global Biologics and Biosimilars Consumption Value by Application (2018-2029)
6.3 Global Biologics and Biosimilars Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Biologics and Biosimilars Sales Quantity by Type (2018-2029)
7.2 North America Biologics and Biosimilars Sales Quantity by Application (2018-2029)
7.3 North America Biologics and Biosimilars Market Size by Country
7.3.1 North America Biologics and Biosimilars Sales Quantity by Country (2018-2029)
7.3.2 North America Biologics and Biosimilars Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Biologics and Biosimilars Sales Quantity by Type (2018-2029)
8.2 Europe Biologics and Biosimilars Sales Quantity by Application (2018-2029)
8.3 Europe Biologics and Biosimilars Market Size by Country
8.3.1 Europe Biologics and Biosimilars Sales Quantity by Country (2018-2029)
8.3.2 Europe Biologics and Biosimilars Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biologics and Biosimilars Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Biologics and Biosimilars Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Biologics and Biosimilars Market Size by Region
9.3.1 Asia-Pacific Biologics and Biosimilars Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Biologics and Biosimilars Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Biologics and Biosimilars Sales Quantity by Type (2018-2029)
10.2 South America Biologics and Biosimilars Sales Quantity by Application (2018-2029)
10.3 South America Biologics and Biosimilars Market Size by Country
10.3.1 South America Biologics and Biosimilars Sales Quantity by Country (2018-2029)
10.3.2 South America Biologics and Biosimilars Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biologics and Biosimilars Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Biologics and Biosimilars Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Biologics and Biosimilars Market Size by Country
11.3.1 Middle East & Africa Biologics and Biosimilars Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Biologics and Biosimilars Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Biologics and Biosimilars Market Drivers
12.2 Biologics and Biosimilars Market Restraints
12.3 Biologics and Biosimilars Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biologics and Biosimilars and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologics and Biosimilars
13.3 Biologics and Biosimilars Production Process
13.4 Biologics and Biosimilars Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologics and Biosimilars Typical Distributors
14.3 Biologics and Biosimilars Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Biologics and Biosimilars Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biologics and Biosimilars Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Biologics and Biosimilars Product and Services
Table 6. Roche Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Biologics and Biosimilars Product and Services
Table 11. Amgen Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Amgen Recent Developments/Updates
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Major Business
Table 15. AbbVie Biologics and Biosimilars Product and Services
Table 16. AbbVie Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AbbVie Recent Developments/Updates
Table 18. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi-Aventis Major Business
Table 20. Sanofi-Aventis Biologics and Biosimilars Product and Services
Table 21. Sanofi-Aventis Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sanofi-Aventis Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Biologics and Biosimilars Product and Services
Table 26. Johnson & Johnson Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. Pfizer Basic Information, Manufacturing Base and Competitors
Table 29. Pfizer Major Business
Table 30. Pfizer Biologics and Biosimilars Product and Services
Table 31. Pfizer Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Pfizer Recent Developments/Updates
Table 33. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 34. Novo Nordisk Major Business
Table 35. Novo Nordisk Biologics and Biosimilars Product and Services
Table 36. Novo Nordisk Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novo Nordisk Recent Developments/Updates
Table 38. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 39. Eli Lilly Major Business
Table 40. Eli Lilly Biologics and Biosimilars Product and Services
Table 41. Eli Lilly Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Eli Lilly Recent Developments/Updates
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Major Business
Table 45. Novartis Biologics and Biosimilars Product and Services
Table 46. Novartis Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Novartis Recent Developments/Updates
Table 48. Merck Basic Information, Manufacturing Base and Competitors
Table 49. Merck Major Business
Table 50. Merck Biologics and Biosimilars Product and Services
Table 51. Merck Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Merck Recent Developments/Updates
Table 53. 3sbio Basic Information, Manufacturing Base and Competitors
Table 54. 3sbio Major Business
Table 55. 3sbio Biologics and Biosimilars Product and Services
Table 56. 3sbio Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. 3sbio Recent Developments/Updates
Table 58. Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table 59. Changchun High Tech Major Business
Table 60. Changchun High Tech Biologics and Biosimilars Product and Services
Table 61. Changchun High Tech Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Changchun High Tech Recent Developments/Updates
Table 63. CP Guojian Basic Information, Manufacturing Base and Competitors
Table 64. CP Guojian Major Business
Table 65. CP Guojian Biologics and Biosimilars Product and Services
Table 66. CP Guojian Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. CP Guojian Recent Developments/Updates
Table 68. Biotech Basic Information, Manufacturing Base and Competitors
Table 69. Biotech Major Business
Table 70. Biotech Biologics and Biosimilars Product and Services
Table 71. Biotech Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Biotech Recent Developments/Updates
Table 73. Gelgen Basic Information, Manufacturing Base and Competitors
Table 74. Gelgen Major Business
Table 75. Gelgen Biologics and Biosimilars Product and Services
Table 76. Gelgen Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Gelgen Recent Developments/Updates
Table 78. Innovent Basic Information, Manufacturing Base and Competitors
Table 79. Innovent Major Business
Table 80. Innovent Biologics and Biosimilars Product and Services
Table 81. Innovent Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Innovent Recent Developments/Updates
Table 83. Dong Bao Basic Information, Manufacturing Base and Competitors
Table 84. Dong Bao Major Business
Table 85. Dong Bao Biologics and Biosimilars Product and Services
Table 86. Dong Bao Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Dong Bao Recent Developments/Updates
Table 88. Ganlee Basic Information, Manufacturing Base and Competitors
Table 89. Ganlee Major Business
Table 90. Ganlee Biologics and Biosimilars Product and Services
Table 91. Ganlee Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Ganlee Recent Developments/Updates
Table 93. United Laboratories Basic Information, Manufacturing Base and Competitors
Table 94. United Laboratories Major Business
Table 95. United Laboratories Biologics and Biosimilars Product and Services
Table 96. United Laboratories Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. United Laboratories Recent Developments/Updates
Table 98. Global Biologics and Biosimilars Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Biologics and Biosimilars Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Biologics and Biosimilars Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 101. Market Position of Manufacturers in Biologics and Biosimilars, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Biologics and Biosimilars Production Site of Key Manufacturer
Table 103. Biologics and Biosimilars Market: Company Product Type Footprint
Table 104. Biologics and Biosimilars Market: Company Product Application Footprint
Table 105. Biologics and Biosimilars New Market Entrants and Barriers to Market Entry
Table 106. Biologics and Biosimilars Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Biologics and Biosimilars Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Biologics and Biosimilars Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Biologics and Biosimilars Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Biologics and Biosimilars Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Biologics and Biosimilars Average Price by Region (2018-2023) & (USD/Unit)
Table 112. Global Biologics and Biosimilars Average Price by Region (2024-2029) & (USD/Unit)
Table 113. Global Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Biologics and Biosimilars Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Biologics and Biosimilars Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Biologics and Biosimilars Average Price by Type (2018-2023) & (USD/Unit)
Table 118. Global Biologics and Biosimilars Average Price by Type (2024-2029) & (USD/Unit)
Table 119. Global Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Biologics and Biosimilars Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Biologics and Biosimilars Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Biologics and Biosimilars Average Price by Application (2018-2023) & (USD/Unit)
Table 124. Global Biologics and Biosimilars Average Price by Application (2024-2029) & (USD/Unit)
Table 125. North America Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Biologics and Biosimilars Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Biologics and Biosimilars Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Biologics and Biosimilars Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Biologics and Biosimilars Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Biologics and Biosimilars Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Biologics and Biosimilars Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Biologics and Biosimilars Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Biologics and Biosimilars Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Biologics and Biosimilars Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Biologics and Biosimilars Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Biologics and Biosimilars Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Biologics and Biosimilars Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Biologics and Biosimilars Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Biologics and Biosimilars Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Biologics and Biosimilars Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Biologics and Biosimilars Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Biologics and Biosimilars Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Biologics and Biosimilars Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Biologics and Biosimilars Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Biologics and Biosimilars Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Biologics and Biosimilars Raw Material
Table 166. Key Manufacturers of Biologics and Biosimilars Raw Materials
Table 167. Biologics and Biosimilars Typical Distributors
Table 168. Biologics and Biosimilars Typical Customers
Table 1. Global Biologics and Biosimilars Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biologics and Biosimilars Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Biologics and Biosimilars Product and Services
Table 6. Roche Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Biologics and Biosimilars Product and Services
Table 11. Amgen Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Amgen Recent Developments/Updates
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Major Business
Table 15. AbbVie Biologics and Biosimilars Product and Services
Table 16. AbbVie Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AbbVie Recent Developments/Updates
Table 18. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi-Aventis Major Business
Table 20. Sanofi-Aventis Biologics and Biosimilars Product and Services
Table 21. Sanofi-Aventis Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sanofi-Aventis Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Biologics and Biosimilars Product and Services
Table 26. Johnson & Johnson Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. Pfizer Basic Information, Manufacturing Base and Competitors
Table 29. Pfizer Major Business
Table 30. Pfizer Biologics and Biosimilars Product and Services
Table 31. Pfizer Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Pfizer Recent Developments/Updates
Table 33. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 34. Novo Nordisk Major Business
Table 35. Novo Nordisk Biologics and Biosimilars Product and Services
Table 36. Novo Nordisk Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novo Nordisk Recent Developments/Updates
Table 38. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 39. Eli Lilly Major Business
Table 40. Eli Lilly Biologics and Biosimilars Product and Services
Table 41. Eli Lilly Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Eli Lilly Recent Developments/Updates
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Major Business
Table 45. Novartis Biologics and Biosimilars Product and Services
Table 46. Novartis Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Novartis Recent Developments/Updates
Table 48. Merck Basic Information, Manufacturing Base and Competitors
Table 49. Merck Major Business
Table 50. Merck Biologics and Biosimilars Product and Services
Table 51. Merck Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Merck Recent Developments/Updates
Table 53. 3sbio Basic Information, Manufacturing Base and Competitors
Table 54. 3sbio Major Business
Table 55. 3sbio Biologics and Biosimilars Product and Services
Table 56. 3sbio Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. 3sbio Recent Developments/Updates
Table 58. Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table 59. Changchun High Tech Major Business
Table 60. Changchun High Tech Biologics and Biosimilars Product and Services
Table 61. Changchun High Tech Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Changchun High Tech Recent Developments/Updates
Table 63. CP Guojian Basic Information, Manufacturing Base and Competitors
Table 64. CP Guojian Major Business
Table 65. CP Guojian Biologics and Biosimilars Product and Services
Table 66. CP Guojian Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. CP Guojian Recent Developments/Updates
Table 68. Biotech Basic Information, Manufacturing Base and Competitors
Table 69. Biotech Major Business
Table 70. Biotech Biologics and Biosimilars Product and Services
Table 71. Biotech Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Biotech Recent Developments/Updates
Table 73. Gelgen Basic Information, Manufacturing Base and Competitors
Table 74. Gelgen Major Business
Table 75. Gelgen Biologics and Biosimilars Product and Services
Table 76. Gelgen Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Gelgen Recent Developments/Updates
Table 78. Innovent Basic Information, Manufacturing Base and Competitors
Table 79. Innovent Major Business
Table 80. Innovent Biologics and Biosimilars Product and Services
Table 81. Innovent Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Innovent Recent Developments/Updates
Table 83. Dong Bao Basic Information, Manufacturing Base and Competitors
Table 84. Dong Bao Major Business
Table 85. Dong Bao Biologics and Biosimilars Product and Services
Table 86. Dong Bao Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Dong Bao Recent Developments/Updates
Table 88. Ganlee Basic Information, Manufacturing Base and Competitors
Table 89. Ganlee Major Business
Table 90. Ganlee Biologics and Biosimilars Product and Services
Table 91. Ganlee Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Ganlee Recent Developments/Updates
Table 93. United Laboratories Basic Information, Manufacturing Base and Competitors
Table 94. United Laboratories Major Business
Table 95. United Laboratories Biologics and Biosimilars Product and Services
Table 96. United Laboratories Biologics and Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. United Laboratories Recent Developments/Updates
Table 98. Global Biologics and Biosimilars Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Biologics and Biosimilars Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Biologics and Biosimilars Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 101. Market Position of Manufacturers in Biologics and Biosimilars, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Biologics and Biosimilars Production Site of Key Manufacturer
Table 103. Biologics and Biosimilars Market: Company Product Type Footprint
Table 104. Biologics and Biosimilars Market: Company Product Application Footprint
Table 105. Biologics and Biosimilars New Market Entrants and Barriers to Market Entry
Table 106. Biologics and Biosimilars Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Biologics and Biosimilars Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Biologics and Biosimilars Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Biologics and Biosimilars Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Biologics and Biosimilars Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Biologics and Biosimilars Average Price by Region (2018-2023) & (USD/Unit)
Table 112. Global Biologics and Biosimilars Average Price by Region (2024-2029) & (USD/Unit)
Table 113. Global Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Biologics and Biosimilars Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Biologics and Biosimilars Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Biologics and Biosimilars Average Price by Type (2018-2023) & (USD/Unit)
Table 118. Global Biologics and Biosimilars Average Price by Type (2024-2029) & (USD/Unit)
Table 119. Global Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Biologics and Biosimilars Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Biologics and Biosimilars Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Biologics and Biosimilars Average Price by Application (2018-2023) & (USD/Unit)
Table 124. Global Biologics and Biosimilars Average Price by Application (2024-2029) & (USD/Unit)
Table 125. North America Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Biologics and Biosimilars Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Biologics and Biosimilars Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Biologics and Biosimilars Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Biologics and Biosimilars Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Biologics and Biosimilars Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Biologics and Biosimilars Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Biologics and Biosimilars Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Biologics and Biosimilars Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Biologics and Biosimilars Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Biologics and Biosimilars Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Biologics and Biosimilars Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Biologics and Biosimilars Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Biologics and Biosimilars Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Biologics and Biosimilars Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Biologics and Biosimilars Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Biologics and Biosimilars Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Biologics and Biosimilars Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Biologics and Biosimilars Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Biologics and Biosimilars Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Biologics and Biosimilars Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Biologics and Biosimilars Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Biologics and Biosimilars Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Biologics and Biosimilars Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Biologics and Biosimilars Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Biologics and Biosimilars Raw Material
Table 166. Key Manufacturers of Biologics and Biosimilars Raw Materials
Table 167. Biologics and Biosimilars Typical Distributors
Table 168. Biologics and Biosimilars Typical Customers
LIST OF FIGURES
Figure 1. Biologics and Biosimilars Picture
Figure 2. Global Biologics and Biosimilars Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biologics and Biosimilars Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies Examples
Figure 5. Interferon Examples
Figure 6. Erythropoietin Examples
Figure 7. Insulin Examples
Figure 8. Vaccines Examples
Figure 9. Others Examples
Figure 10. Global Biologics and Biosimilars Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Biologics and Biosimilars Consumption Value Market Share by Application in 2022
Figure 12. Tumor Examples
Figure 13. Diabetes Examples
Figure 14. Cardiovascular Examples
Figure 15. Hemophilia Examples
Figure 16. Others Examples
Figure 17. Global Biologics and Biosimilars Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Biologics and Biosimilars Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Biologics and Biosimilars Sales Quantity (2018-2029) & (K Units)
Figure 20. Global Biologics and Biosimilars Average Price (2018-2029) & (USD/Unit)
Figure 21. Global Biologics and Biosimilars Sales Quantity Market Share by Manufacturer in 2022
Figure 22. Global Biologics and Biosimilars Consumption Value Market Share by Manufacturer in 2022
Figure 23. Producer Shipments of Biologics and Biosimilars by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 24. Top 3 Biologics and Biosimilars Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Top 6 Biologics and Biosimilars Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Global Biologics and Biosimilars Sales Quantity Market Share by Region (2018-2029)
Figure 27. Global Biologics and Biosimilars Consumption Value Market Share by Region (2018-2029)
Figure 28. North America Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 29. Europe Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 30. Asia-Pacific Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 31. South America Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 32. Middle East & Africa Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 33. Global Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 34. Global Biologics and Biosimilars Consumption Value Market Share by Type (2018-2029)
Figure 35. Global Biologics and Biosimilars Average Price by Type (2018-2029) & (USD/Unit)
Figure 36. Global Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 37. Global Biologics and Biosimilars Consumption Value Market Share by Application (2018-2029)
Figure 38. Global Biologics and Biosimilars Average Price by Application (2018-2029) & (USD/Unit)
Figure 39. North America Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 40. North America Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 41. North America Biologics and Biosimilars Sales Quantity Market Share by Country (2018-2029)
Figure 42. North America Biologics and Biosimilars Consumption Value Market Share by Country (2018-2029)
Figure 43. United States Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Canada Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Mexico Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Europe Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 47. Europe Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 48. Europe Biologics and Biosimilars Sales Quantity Market Share by Country (2018-2029)
Figure 49. Europe Biologics and Biosimilars Consumption Value Market Share by Country (2018-2029)
Figure 50. Germany Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. France Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. United Kingdom Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Russia Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Italy Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Asia-Pacific Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 56. Asia-Pacific Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 57. Asia-Pacific Biologics and Biosimilars Sales Quantity Market Share by Region (2018-2029)
Figure 58. Asia-Pacific Biologics and Biosimilars Consumption Value Market Share by Region (2018-2029)
Figure 59. China Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Japan Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Korea Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. India Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Southeast Asia Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Australia Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. South America Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 66. South America Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 67. South America Biologics and Biosimilars Sales Quantity Market Share by Country (2018-2029)
Figure 68. South America Biologics and Biosimilars Consumption Value Market Share by Country (2018-2029)
Figure 69. Brazil Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Argentina Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Middle East & Africa Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 72. Middle East & Africa Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 73. Middle East & Africa Biologics and Biosimilars Sales Quantity Market Share by Region (2018-2029)
Figure 74. Middle East & Africa Biologics and Biosimilars Consumption Value Market Share by Region (2018-2029)
Figure 75. Turkey Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Egypt Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Saudi Arabia Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. South Africa Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. Biologics and Biosimilars Market Drivers
Figure 80. Biologics and Biosimilars Market Restraints
Figure 81. Biologics and Biosimilars Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2022
Figure 84. Manufacturing Process Analysis of Biologics and Biosimilars
Figure 85. Biologics and Biosimilars Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
Figure 1. Biologics and Biosimilars Picture
Figure 2. Global Biologics and Biosimilars Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biologics and Biosimilars Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies Examples
Figure 5. Interferon Examples
Figure 6. Erythropoietin Examples
Figure 7. Insulin Examples
Figure 8. Vaccines Examples
Figure 9. Others Examples
Figure 10. Global Biologics and Biosimilars Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Biologics and Biosimilars Consumption Value Market Share by Application in 2022
Figure 12. Tumor Examples
Figure 13. Diabetes Examples
Figure 14. Cardiovascular Examples
Figure 15. Hemophilia Examples
Figure 16. Others Examples
Figure 17. Global Biologics and Biosimilars Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Biologics and Biosimilars Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Biologics and Biosimilars Sales Quantity (2018-2029) & (K Units)
Figure 20. Global Biologics and Biosimilars Average Price (2018-2029) & (USD/Unit)
Figure 21. Global Biologics and Biosimilars Sales Quantity Market Share by Manufacturer in 2022
Figure 22. Global Biologics and Biosimilars Consumption Value Market Share by Manufacturer in 2022
Figure 23. Producer Shipments of Biologics and Biosimilars by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 24. Top 3 Biologics and Biosimilars Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Top 6 Biologics and Biosimilars Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Global Biologics and Biosimilars Sales Quantity Market Share by Region (2018-2029)
Figure 27. Global Biologics and Biosimilars Consumption Value Market Share by Region (2018-2029)
Figure 28. North America Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 29. Europe Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 30. Asia-Pacific Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 31. South America Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 32. Middle East & Africa Biologics and Biosimilars Consumption Value (2018-2029) & (USD Million)
Figure 33. Global Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 34. Global Biologics and Biosimilars Consumption Value Market Share by Type (2018-2029)
Figure 35. Global Biologics and Biosimilars Average Price by Type (2018-2029) & (USD/Unit)
Figure 36. Global Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 37. Global Biologics and Biosimilars Consumption Value Market Share by Application (2018-2029)
Figure 38. Global Biologics and Biosimilars Average Price by Application (2018-2029) & (USD/Unit)
Figure 39. North America Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 40. North America Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 41. North America Biologics and Biosimilars Sales Quantity Market Share by Country (2018-2029)
Figure 42. North America Biologics and Biosimilars Consumption Value Market Share by Country (2018-2029)
Figure 43. United States Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Canada Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Mexico Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Europe Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 47. Europe Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 48. Europe Biologics and Biosimilars Sales Quantity Market Share by Country (2018-2029)
Figure 49. Europe Biologics and Biosimilars Consumption Value Market Share by Country (2018-2029)
Figure 50. Germany Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. France Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. United Kingdom Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Russia Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Italy Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Asia-Pacific Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 56. Asia-Pacific Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 57. Asia-Pacific Biologics and Biosimilars Sales Quantity Market Share by Region (2018-2029)
Figure 58. Asia-Pacific Biologics and Biosimilars Consumption Value Market Share by Region (2018-2029)
Figure 59. China Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Japan Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Korea Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. India Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Southeast Asia Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Australia Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. South America Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 66. South America Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 67. South America Biologics and Biosimilars Sales Quantity Market Share by Country (2018-2029)
Figure 68. South America Biologics and Biosimilars Consumption Value Market Share by Country (2018-2029)
Figure 69. Brazil Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Argentina Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Middle East & Africa Biologics and Biosimilars Sales Quantity Market Share by Type (2018-2029)
Figure 72. Middle East & Africa Biologics and Biosimilars Sales Quantity Market Share by Application (2018-2029)
Figure 73. Middle East & Africa Biologics and Biosimilars Sales Quantity Market Share by Region (2018-2029)
Figure 74. Middle East & Africa Biologics and Biosimilars Consumption Value Market Share by Region (2018-2029)
Figure 75. Turkey Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Egypt Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Saudi Arabia Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. South Africa Biologics and Biosimilars Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. Biologics and Biosimilars Market Drivers
Figure 80. Biologics and Biosimilars Market Restraints
Figure 81. Biologics and Biosimilars Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2022
Figure 84. Manufacturing Process Analysis of Biologics and Biosimilars
Figure 85. Biologics and Biosimilars Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
